FBInvestor
Stocks / Enliven Therapeutics Inc
Institutional Ownership

Enliven Therapeutics Inc

CUSIP 29337E102COMELVNQ1 2026

Analyst forecast

Analyst recommendation trends (Buy / Hold / Sell consensus) come from a market-data feed. This activates once the forecast feed is connected and this ticker is covered.

Coming soon